Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: A review

Since late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, better known as COVID-19) has rapidly spread worldwide. The primary pathophysiology by which COVID-19 leads to severe lung damage is cytokine releasing syndrome (CRS), which can cause death. Therefore, removing cytokines v...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokouhi, Shervin, Barati, Saghar, Kazeminia, Neda, Jamali, Faezeh, Roshan, Baran, Sahraei, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059942/
https://www.ncbi.nlm.nih.gov/pubmed/33962224
http://dx.doi.org/10.1016/j.intimp.2021.107707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059942/
https://www.ncbi.nlm.nih.gov/pubmed/33962224
http://dx.doi.org/10.1016/j.intimp.2021.107707

Ejemplares similares